Voya Investment Management LLC Raises Stock Position in Select Medical Holdings Corporation $SEM

Key Points

• Voya Investment Management LLC increased its stake in Select Medical Holdings Corporation by 48.7%, owning 1.17% of the company worth approximately $25.17 million after acquiring additional shares.
• Select Medical reported earnings of $0.32 per share for the last quarter, beating estimates, while revenue reached $1.34 billion, slightly below analysts' expectations.
• The company set its FY 2025 guidance at EPS of 1.090-1.19, with analysts predicting a current fiscal year EPS of 1.17 and a moderate buy consensus rating.

Voya Investment Management LLC raised its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 48.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,507,349 shares of the health services provider's stock after acquiring an additional 493,983 shares during the quarter. Voya Investment Management LLC owned approximately 1.17% of Select Medical worth $25,173,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Caitong International Asset Management Co. Ltd increased its holdings in Select Medical by 61.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock valued at $45,000 after purchasing an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in Select Medical during the 1st quarter valued at approximately $60,000. Advisors Asset Management Inc. raised its position in Select Medical by 168.2% during the 1st quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider's stock valued at $105,000 after purchasing an additional 3,952 shares during the last quarter. GAMMA Investing LLC raised its position in Select Medical by 217.4% during the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after purchasing an additional 4,453 shares during the last quarter. Finally, Lazard Asset Management LLC raised its position in Select Medical by 47.8% during the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the last quarter. 89.48% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Bank of America lowered their price target on Select Medical from $18.00 to $15.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. UBS Group restated a "neutral" rating and issued a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $19.20.

Select Medical Stock Performance

SEM stock traded down $0.25 during midday trading on Friday, reaching $12.38. 2,355,341 shares of the company's stock traded hands, compared to its average volume of 844,700. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $40.98. The stock has a market cap of $1.53 billion, a P/E ratio of 11.68, a PEG ratio of 0.52 and a beta of 1.25. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92. The stock's 50-day moving average is $13.17 and its 200 day moving average is $14.92.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company's revenue was up 4.5% on a year-over-year basis. During the same period last year, the firm earned $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Wednesday, August 13th were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical's dividend payout ratio (DPR) is presently 23.58%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.